Several Indian companies are preparing to launch generic versions of GLP-1 category drug Semaglutide in India ...
LONDON/COPENHAGEN, Dec 23 (Reuters) - Novo Nordisk secured U.S. regulatory approval for its weight-loss pill, giving the Danish drugmaker a shot at reclaiming ground lost to rival Eli Lilly. Booming ...
Some tout a daily semaglutide pill as a game-changer for weight-loss treatment. The Food and Drug Administration has approved the first GLP-1 pill for weight loss and maintenance. Drugmaker Novo ...
Billboard has announced an upcoming shift in its chart tabulation that will give more weight to music streaming against album sales. Starting in January, the magazine and authoritative record of music ...
Ahead of its Capital Markets Day Thursday, Zealand Pharma unveiled its "Metabolic Frontier 2030" strategy. The strategy comes as Zealand shares have dropped 29% year to date, with investors betting on ...
Hosted on MSN
Weight loss trends 2025: The real fitness chart — what worked and what failed this year
Weight Loss Trends 2025: The biggest fitness trend of 2025 was simple — people chose routines that were easy, enjoyable, and stress-free. Strict diets and exhausting workout regimes took a backseat, ...
Research shows the battle to keep weight off isn’t about willpower—it’s biology. Here’s how scientists say we can work with our bodies, not against them. Our bodies evolved to survive famine, not ...
Lauren O’Connor, MS, RDN, is a health and lifestyle writer and five-time cookbook author based in Los Angeles. She is a registered dietitian with over 15 years of experience in the field, specializing ...
Follow along as we build a weight loss tracker in Google Sheets from scratch. You’ll learn how to enter goals, log progress, adjust charts, and print your tracker for an easy way to stay on top of ...
Forbes contributors publish independent expert analyses and insights. I write about TV shows, movies, video games, entertainment & culture. Dwayne ‘The Rock’ Johnson, the professional wrestler best ...
LONDON/COPENHAGEN (Reuters) -Danish drugmaker Novo Nordisk is facing a major challenge to its blockbuster weight-loss drug Wegovy. Booming sales of Wegovy powered the company to become Europe's most ...
Baker Hughes said on Tuesday it will buy Chart Industries in a $13.6 billion all-cash deal, including debt, to expand in the LNG, data centers and decarbonization segments, edging out rival suitor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results